Raised Outlooks and a Cancer Approval Arrive in the Middle of Medicare Open Enrollment
Edwards Lifesciences Corp EW
News
Edwards Lifesciences Reports Third Quarter Results
CLASP II TR Trial Demonstrates Superior Clinical, Quality-of-Life Benefits With Edwards PASCAL System
Progress Trial Demonstrates Edwards TAVR Is Superior to Clinical Surveillance for Moderate AS Patients With At-Risk Features
7 healthcare stocks that stand out as investors pay up for the sector
7 healthcare stocks that stand out as -2-
FDA Approval of Edwards Lifesciences’ PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve Disease
Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
Edwards Lifesciences to Host Investor Event in Conjunction With TCT
Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
Edwards Lifesciences Comments on TAVR National Coverage Decision
Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?
Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit
Stocks to Watch: Intel, Deckers, Edwards Lifesciences, Genmab
Edwards Lifesciences, Genesis MedTech to Pay Combined $12 Million to Settle FTC Charges — Update
Edwards Lifesciences, Genesis MedTech to Pay Combined $12 Million to Settle FTC Charges
Edwards Lifesciences Drops Merger With JenaValve
United States